Afya (NASDAQ:AFYA) Shares Gap Down – Time to Sell?

Shares of Afya Limited (NASDAQ:AFYA – Get Free Report) gapped down before the market opened on Monday. The stock had previously closed at $15.09, but opened at $11.71. Afya shares last traded at $12.2050, with a volume of 133,298 shares changing hands.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on AFYA shares. Bradesco Corretora upgraded Afya to an “outperform” rating and set a $17.00 price target for the company in a report on Thursday, September 24th. Weiss Ratings lowered shares of Afya from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, July 31st. JPMorgan Chase & Co. raised shares of Afya from a “neutral” rating to an “overweight” rating and decreased their target price for the company from $21.00 to $19.00 in a research report on Wednesday, October 7th. Zacks Research raised shares of Afya from a “strong sell” rating to a “hold” rating in a research note on Monday, October 5th. Finally, Wall Street Zen raised shares of Afya from a “hold” rating to a “buy” rating in a research note on Saturday, September 5th. Two equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $17.25.

Check Out Our Latest Research Report on Afya

Afya Stock Down 27.8%

The company has a market capitalization of $1.02 billion, a PE ratio of 6.62, a PEG ratio of 1.83 and a beta of 0.34. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39. The business has a fifty day moving average of $13.97 and a 200 day moving average of $14.23.

Afya (NASDAQ:AFYA – Get Free Report) last announced its quarterly earnings data on Friday, August 14th. The company reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.40 by $0.03. The business had revenue of $187.80 million for the quarter, compared to analysts’ expectations of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. Equities research analysts anticipate that Afya Limited will post 1.72 EPS for the current year.

Insiders Place Their Bets

In related news, insider Santos Welder Ferreira sold 4,161 shares of Afya stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $13.30, for a total value of $55,341.30. Following the completion of the transaction, the insider owned 35,000 shares in the company, valued at $465,500. The trade was a 10.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Afya stock. Engineers Gate Manager LP acquired a new stake in Afya Limited (NASDAQ:AFYA – Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 21,882 shares of the company’s stock, valued at approximately $325,000. Institutional investors and hedge funds own 88.02% of the company’s stock.

Afya Company Profile

(Get Free Report)

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.

See Also

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.